More SEC Filings
View Older Stories View Newer Stories-
Form 4 AGNC Investment Corp. For: Mar 16 Filed by: Reid Sean
-
Form DEF 14C FEDERATED HERMES, INC. For: Dec 31
-
Form 8-K AN2 Therapeutics, Inc. For: Mar 17
-
Form 144 VICOR CORP Filed by: McNamara Michael
-
Form POSASR Gossamer Bio, Inc.
-
Form MA-A S L Capital Strategies For: Dec 31
-
Form 4 Diamondback Energy, Inc. For: Mar 13 Filed by: Zmigrosky Matt
-
Form 424B2 MORGAN STANLEY
-
Form DEFM14A Tri Pointe Homes, Inc.
-
Form 4 Diamondback Energy, Inc. For: Mar 13 Filed by: Barkmann Albert
-
Form 4 Diamondback Energy, Inc. For: Mar 16 Filed by: Thompson Jere W III
-
Form 497 AIM GROWTH SERIES (INVES
-
Form PRE 14A Atomera Inc For: May 12
-
Form 497 AIM INVESTMENT FUNDS
-
Form 497 AIM COUNSELOR SERIES
-
Form 497 AIM VARIABLE INSURANCE
-
Form 3 Immatics N.V. For: Mar 17 Filed by: Hothum Mathias
-
Form 497 AIM INTERNATIONAL MUTUAL
-
Form 4 AGNC Investment Corp. For: Mar 16 Filed by: Kain Gary D
-
Form 3 Mega Matrix Inc For: Dec 18 Filed by: Chen Yunhao
-
Form 144 PEGASYSTEMS INC Filed by: KOUNINIS EFSTATHIOS A
-
Form 4 Dakota Gold Corp. For: Mar 13 Filed by: SCHROEDER ALICE D.
-
Form 4 QVC Group, Inc. For: Mar 15 Filed by: Bowe Stacy
-
Form 8-K Fold Holdings, Inc. For: Mar 17
-
Form 10-K Longeveron Inc. For: Dec 31
-
Form SCHEDULE 13D/A Fold Holdings, Inc. Filed by: Fulgur Frontier Capital LP
-
Form 6-K Brainsway Ltd. For: Mar 17
-
Form 4 AGNC Investment Corp. For: Mar 16 Filed by: Federico Peter J
-
Form 4 LANDSTAR SYSTEM INC For: Mar 15 Filed by: Miller Matthew
-
Form 8-K Drugs Made In America For: Mar 11
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 10-K Kalaris Therapeutics, For: Dec 31
-
Form 424B5 SAB Biotherapeutics,
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B3 CRESCENT BIOPHARMA, INC.
-
Form 8-K Arthur J. Gallagher & For: Mar 17
-
Form F-3 Wetour Robotics Ltd
-
Form 424B2 CITIGROUP INC
-
Form 8-K MANGOCEUTICALS, INC. For: Mar 16
-
Form 3/A Cantor Equity Partners For: Dec 30 Filed by: Fulgur Frontier Capital LP
-
Form 4/A Fold Holdings, Inc. For: Dec 30 Filed by: Fulgur Frontier Capital LP
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 8-K Waterstone Financial, For: Mar 17
-
Form 4 Purple Innovation, Inc. For: Mar 15 Filed by: DeMartini Robert
-
Form 4 Purple Innovation, Inc. For: Mar 15 Filed by: KERBY JEFFERY SCOTT
-
Form 4 Purple Innovation, Inc. For: Mar 15 Filed by: HAYNOR ERIC SCOTT
-
Form 6-K KAMADA LTD For: Mar 17
-
Form 424B2 CITIGROUP INC
-
Form 4 Purple Innovation, Inc. For: Mar 14 Filed by: Vogensen Todd E.
-
Form 4 Purple Innovation, Inc. For: Mar 15 Filed by: Ulrich George Turner

